Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 949656, 9 pages
http://dx.doi.org/10.1155/2015/949656
Research Article

Protective and Therapeutic Effects of Chinese Medicine Formula Jiajian Yunvjian on Experimental Cardiac Remodeling after Myocardial Infarction Induced by Coronary Artery Ligation

Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Received 19 January 2015; Revised 29 May 2015; Accepted 1 June 2015

Academic Editor: Kuttulebbai N. S. Sirajudeen

Copyright © 2015 Jun Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Katz, Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2000.
  2. Y. Gao, J. P. Gao, C. X. Chen, H. L. Wang, J. Guo, and R. Wu, “Beneficial effects of houttuynin on ventricular remodeling induced by coronary artery ligation in rats,” European Journal of Pharmacology, vol. 740, pp. 200–208, 2014. View at Publisher · View at Google Scholar
  3. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler, “The sympathetic nervous system in heart failure. physiology, pathophysiology, and clinical implications,” Journal of the American College of Cardiology, vol. 54, no. 19, pp. 1747–1762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Yuan, H. Sunouchi, T. Sakurai, K. Saito, and Y. Kano, “Pharmacological properties of traditional medicines (XXVII). Interaction between Ephedra Herb and Gypsum under hyperthermal conditions in rats,” Biological and Pharmaceutical Bulletin, vol. 25, no. 7, pp. 872–874, 2002. View at Google Scholar
  5. J. K. Oh, S. Y. Hyun, H. R. Oh et al., “Effects of Anemarrhena asphodeloides on focal ischemic brain injury induced by middle cerebral artery occlusion in rats,” Biological and Pharmaceutical Bulletin, vol. 30, no. 1, pp. 38–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S.-Z. Xiao, M.-E. Xu, Y.-K. Ge, and G.-F. Xiao, “Inhibitory effects of saponins from Anemarrhena asphodeloides Bunge on the growth of vascular smooth muscle cells,” Biomedical and Environmental Sciences, vol. 19, no. 3, pp. 185–191, 2006. View at Google Scholar · View at Scopus
  7. W.-L. Gu, C.-X. Chen, Q. Wu, J. Lü, Y. Liu, and S.-J. Zhang, “Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling,” Pharmazie, vol. 65, no. 10, pp. 770–775, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Y. Huang, C. X. Chen, X. M. Zhang, Y. Liu, X. M. Wu, and Y. M. Li, “Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats,” Phytomedicine, vol. 19, no. 3-4, pp. 193–205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-S. Li, Z.-J. Chen, and D.-Y. Zhu, “A novel bis-furan derivative, two new natural furan derivatives from Rehmannia glutinosa and their bioactivity,” Natural Product Research, vol. 19, no. 2, pp. 165–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S.-S. Kim, Y.-O. Son, J.-C. Chun et al., “Antioxidant property of an active component purified from the leaves of paraquat-tolerant Rehmannia glutinosa,” Redox Report, vol. 10, no. 6, pp. 311–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zhou, G. Xu, J. Yan et al., “Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice,” Journal of Ethnopharmacology, vol. 164, pp. 229–238, 2015. View at Publisher · View at Google Scholar
  12. J. Kou, B. Yu, and Q. Xu, “Inhibitory effects of ethanol extract from Radix Ophiopogon japonicus on venous thrombosis linked with its endothelium-protective and anti-adhesive activities,” Vascular Pharmacology, vol. 43, no. 3, pp. 157–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Kou, Y. Tian, Y. Tang, J. Yan, and B. Yu, “Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents,” Biological and Pharmaceutical Bulletin, vol. 29, no. 6, pp. 1267–1270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. C. Trindade, R. C. Trindade, M. P. Marassi et al., “Role of renin-angiotensin system in development of heart failure induced by myocardial infarction in rats,” Anais da Academia Brasileira de Ciencias, vol. 79, no. 2, pp. 251–259, 2007. View at Google Scholar · View at Scopus
  15. M. Shimoyama, D. Hayashi, E. Takimoto et al., “Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy,” Circulation, vol. 100, no. 24, pp. 2449–2454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhou, P. Gan, L. Hao et al., “Antiinflammatory effects of orientin-2"-O-galactopyranoside on lipopolysaccharide-stimulated microglia,” Biological and Pharmaceutical Bulletin, vol. 37, no. 8, pp. 1282–1294, 2014. View at Publisher · View at Google Scholar
  17. T. Shinzato, Y. Ohya, M. Nakamoto, A. Ishida, and S. Takishita, “Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats,” Hypertension Research, vol. 30, no. 9, pp. 863–873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar
  19. S. R. Tiyyagura and S. P. Pinney, “Left ventricular remodeling after myocardial infarction: past, present, and future,” Mount Sinai Journal of Medicine, vol. 73, no. 6, pp. 840–851, 2006. View at Google Scholar · View at Scopus
  20. C. Delcayre, J. S. Silvestre, A. Garnier et al., “Cardiac aldosterone production and ventricular remodeling,” Kidney International, vol. 57, no. 4, pp. 1346–1351, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Hsueh, Y. S. Do, and R. Jeyaseelan, “Angiotensin II and cardiac remodeling,” Mount Sinai Journal of Medicine, vol. 65, no. 2, pp. 104–107, 1998. View at Google Scholar
  22. C. Pellieux, A. Foletti, G. Peduto et al., “Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2,” Journal of Clinical Investigation, vol. 108, no. 12, pp. 1843–1851, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. C. G. Brilla, G. Zhou, L. Matsubara, and K. T. Weber, “Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone,” Journal of Molecular and Cellular Cardiology, vol. 26, no. 7, pp. 809–820, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Takano, H. Hasegawa, T. Nagai, and I. Komuro, “Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies,” Internal Medicine, vol. 42, no. 6, pp. 465–469, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Watanabe, T. A. Barker, and B. C. Berk, “Angiotensin II and the endothelium: diverse signals and effects,” Hypertension, vol. 45, no. 2, pp. 163–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr. et al., “Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats,” Circulation, vol. 97, no. 14, pp. 1382–1391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-C. Fu, C.-S. Chi, S.-C. Yin, B. Hwang, Y.-T. Chiu, and S.-L. Hsu, “Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNFα-caspase signaling pathway,” Cardiovascular Research, vol. 62, no. 3, pp. 558–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Gurantz, R. T. Cowling, F. J. Villarreal, and B. H. Greenberg, “Tumor necrosis factor-α upregulates angiotensin II type 1 receptors on cardiac fibroblasts,” Circulation Research, vol. 85, no. 3, pp. 272–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Bujak and N. G. Frangogiannis, “The role of TGF-β signaling in myocardial infarction and cardiac remodeling,” Cardiovascular Research, vol. 74, no. 2, pp. 184–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Rosenkranz, “TGF-β1 and angiotensin networking in cardiac remodeling,” Cardiovascular Research, vol. 63, no. 3, pp. 423–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ikeuchi, H. Tsutsui, T. Shiomi et al., “Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction,” Cardiovascular Research, vol. 64, no. 3, pp. 526–535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. G. P. Diniz, M. S. Carneiro-Ramos, and M. L. M. Barreto-Chaves, “Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-β1 in thyroid hormone-induced cardiac hypertrophy,” Pflugers Archiv European Journal of Physiology, vol. 454, no. 1, pp. 75–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. O. Gray, C. S. Long, J. E. Kalinyak, H.-T. Li, and J. S. Karliner, “Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts,” Cardiovascular Research, vol. 40, no. 2, pp. 352–363, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. M. D. Schneider, “Serial killer: angiotensin drives cardiac hypertrophy via TGF-β1,” The Journal of Clinical Investigation, vol. 109, no. 6, pp. 715–716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. X.-S. Zhao, W. Pan, R. Bekeredjian, and R. V. Shohet, “Endogenous endothelin-1 is required for cardiomyocyte survival in vivo,” Circulation, vol. 114, no. 8, pp. 830–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. T. Nguyen, P. Cernacek, A. Calderoni et al., “Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat,” Circulation, vol. 98, no. 21, pp. 2323–2330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Iwanaga, Y. Kihara, K. Hasegawa et al., “Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats,” Circulation, vol. 98, no. 19, pp. 2065–2073, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Lerman, F. L. Hildebrand Jr., L. L. Aarhus, and J. C. Burnett Jr., “Endothelin has biological actions at pathophysiological concentrations,” Circulation, vol. 83, no. 5, pp. 1808–1814, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Ruiz-Stewart, S. R. Tiyyagura, J. E. Lin et al., “Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 37–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Tiyyagura, S. Kazerounian, S. Schulz, S. A. Waldman, and G. M. Pitari, “Reciprocal regulation and integration of signaling by intracellular calcium and cyclic GMP,” Vitamins & Hormones, vol. 69, pp. 69–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. T.-H. Cheng, N.-L. Shih, S.-Y. Chen et al., “Nitric oxide inhibits endothelin-1-induced cardiomyocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation,” Molecular Pharmacology, vol. 68, no. 4, pp. 1183–1192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Miyamoto, Y. Takeishi, T. Shishido et al., “Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits,” Japanese Heart Journal, vol. 44, no. 1, pp. 127–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. K. T. Weber and C. G. Brilla, “Structural basis for pathologic left ventricular hypertrophy,” Clinical Cardiology, vol. 16, no. 5, pp. II10–II14, 1993. View at Google Scholar · View at Scopus
  44. T. Makino, Y. Ito, S.-Y. Sasaki, Y. Fujimura, and Y. Kano, “Preventive and curative effects of Gyokuheifu-san, a formula of traditional Chinese medicine, on allergic rhinitis induced with Japanese cedar pollens in guinea pig,” Biological and Pharmaceutical Bulletin, vol. 27, no. 4, pp. 554–558, 2004. View at Publisher · View at Google Scholar · View at Scopus